Licensing discussions often begin with one question: which patents can we sell? At IP Stars Korea in Seoul, we asked 180+ IP professionals a different question: which market, business objective, and licensing model is your organization prepared to invest in?
The difference matters. Many companies have completed licensing or patent-sale transactions, but fewer have built a licensing function that regularly produces deals. According to IP Daily's post-event coverage, attendance was well above the roughly 100 originally expected and included Korean IP authorities, corporates, research institutions, universities, law firms, and IP monetization firms. This article summarizes the framework we shared and the project experience behind it.
How a Transaction Differs From a Licensing Business
A single transaction usually begins with one patent and a specific opportunity. The team analyzes that deal; success means a signed agreement, and what the team learns stays with the people involved.
A licensing business begins with market and business objectives. It generates its own opportunities, applies consistent criteria and processes, and measures success by pipeline strength. Knowledge from each deal is retained and reused across the organization.
Four Questions That Shape a Licensing Program
We organize the work around four questions:
- Where should we play? Which markets and technology areas can support a licensing program?
- What is our real leverage? How do patent strength, evidence, and capabilities translate into negotiating power?
- What is the right model and value? Which monetization model and economics give the best return for the enterprise?
- How do we win and scale? What pipeline, operating model, and internal capability are needed to repeat success?
In our projects, three assumptions often cause problems. A large portfolio still needs clustering, prioritization, and program design before it is ready for the market. Strong patents give negotiating power when backed by evidence, transferability, or commercial capability. One successful deal shows what is possible; repeating it requires data, processes, and institutional knowledge.
1. Where Should We Play?
In a global electronics project, the client held more than 10,000 patents. We grouped the portfolio by technology and application and assessed each group on market size, claim strength, external detectability, and idea utility. This produced licensing programs organized around specific markets, with patent packages built for each commercial opportunity.
2. What Is Our Real Leverage?
Strong patents establish a starting position. Evidence that connects those patents to real products and operations strengthens the negotiation. The type of evidence depends on the industry.
In ICT and electronics, the main question is who uses the technology. Evidence comes from product analysis, evidence of use (EoU), and standards and infringement mapping. The pool of potential licensees is usually broad, and the licensing package centers on patents.
In one project, a client with a strong standard-essential patent (SEP) portfolio could not demonstrate implementation convincingly from public sources. We built the evidence through product testing, reverse engineering, packet capture, and standards mapping. The client entered negotiations with defensible EoU and a credible position to enforce.
In chemicals and materials, the main question is who can implement and commercialize the technology. Licensees assess whether it transfers through the patent alone or requires know-how, whether lab results hold at commercial scale, and what facilities, raw materials, yield, regulatory compliance, market access, and technical support are needed. Potential partners are fewer, and packages typically combine patents, know-how, and ongoing support.
3. What Is the Right Model and Value?
A single portfolio can support several monetization routes, including patent licensing, technology transfer, co-development, joint ventures, patent pools, asset sales, selective enforcement, and supply-plus-services arrangements.
In one engagement, the client planned a traditional licensing program. Our analysis showed the industry would resist an enforcement-led approach, so we evaluated six alternatives: patent licensing, technology licensing, a patent pool, partnership, asset sale, and selective enforcement. We compared them on net present value, investment required, time to cash, risk, and reputational impact within the industry. The option with the highest royalty rate often differs from the option with the highest overall value, so the full deal structure deserves as much attention as the headline terms.
4. How Do We Win and Scale?
Before an agreement, the work covers portfolio readiness, market and target selection, evidence development, package design, valuation, and a negotiation playbook. After signing, it continues with royalty and compliance monitoring, tracking new products and markets, identifying additional licensees, strengthening the portfolio, and feeding insights back into R&D and filing decisions. Each agreement improves the data and assets available for the next one.
AI supports this work at scale in four areas: screening portfolios through classification, clustering, and prioritization; connecting patents to markets, products, and partners; speeding up document and claim analysis; and monitoring products, standards, M&A activity, and expansion signals. Domain experts remain responsible for strategy and decisions, while AI makes continuous monitoring practical in place of periodic reviews.
The View From Korea
From my perspective working with companies across Korea and the broader APAC region, interest in IP monetization is clearly increasing. But a significant gap remains between recognizing a patent portfolio's value and building an organization that can systematically turn that value into recurring business opportunities.
In many Asian companies, licensing activity can still be triggered by a particular portfolio, dispute, or external opportunity. The challenge is moving from that event-driven approach to a more deliberate model: deciding where the company wants to play, identifying monetization opportunities before they become obvious, building the evidence and internal capabilities needed to pursue them, and creating a pipeline that can continue over time.
This is particularly relevant in Korea, where many companies have accumulated substantial patent portfolios and strong technology positions through decades of R&D investment. The next question is not simply whether those patents can be monetized, but how IP can be connected more systematically to business strategy and become another source of enterprise value.
That was one reason the discussion at IP Stars Korea was encouraging. Strong participation from government, corporates, research institutions, universities, and the broader IP ecosystem suggested the conversation is increasingly moving beyond patent creation and protection toward using IP more actively as a business asset.
IP Daily described our session as a practical guide to sustainable global IP monetization and reported our main recommendation: build a monetization structure around the target market instead of licensing patents one at a time. At the same event, Sara Jeon was named one of six recipients of the World IP STARS 2026 recognition for contributions to global IP monetization and IP finance.
A Starting Point for Your Next Program
The question we opened with is the one we asked attendees to take back to their organizations. Deciding which market to pursue, what value to create, and which licensing model to commit to sets the direction for the four questions above. Those decisions form the basis of a licensing program that keeps producing deals after the first one closes.
